Nov
28
The mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) market is expected to gain growth at a potential rate of 3.0% in the forecast period of 2021 to 2028. The increase in the investment in research and development is the factor responsible for the market growth.
11-28-23 - 11:00 Date de début
11-29-23 - 12:00 Date de fin
Europe
